US Stock Market Move | Q2 revenue and profits both exceed expectations, Abbott Laboratories (ABT.US) rises over 12%.

On Thursday, Abbott Laboratories (ABT.US) stock price surged, rising over 12% to $99.96 as of press time. The financial report shows that Abbott Laboratories' revenue in the second quarter was $12.59 billion, a year-on-year increase of 13.0%, exceeding market expectations; adjusted earnings per share were $1.31, surpassing expectations by $0.03. In a statement released on Thursday, the company indicated that it is currently forecasting adjusted earnings per share for the year to be between $5.45 and $5.60, with the midpoint increasing by 5 cents; the company reiterated its full-year same-store sales growth expectations for 2026 to be between 6.5% and 7.5%.